๐Ÿ’Š Oral GLP-1๐Ÿ”ฌ Phase 3๐Ÿข Eli Lilly

Orforglipron Tracker App

Track Your Orforglipron Protocol

Orforglipron is an oral glp-1 (lilly) used in ATTAIN with 14.7% weight loss at 36 weeks. Shotlee is the free app to track your complete Orforglipron protocol โ€” doses, side effects, weight, and labs.

25,000+

Active Users

4.8โ˜…

App Rating

Free

Always Free

What Is Orforglipron?

Orforglipron is an oral glp-1 (lilly) used in ATTAIN with 14.7% weight loss at 36 weeks. Shotlee is the free app to track your complete Orforglipron protocol โ€” doses, side effects, weight, and labs.

Shotlee tracks every aspect of your Orforglipron protocol: injection dates, doses, sites, side effects, weight changes, and lab results. Whether you are starting or optimizing, clean data makes better decisions.

What to Track in Shotlee

Build a complete Orforglipron protocol record from day one.

๐Ÿ’‰

Dose Log

Record every injection date, dose amount, and administration route.

โš–๏ธ

Weekly Weight

Track body weight consistently to see your response curve over time.

๐Ÿคข

Side Effects

Log any side effects with severity ratings to share with your prescriber.

๐Ÿฉธ

Lab Results

Save blood work and biomarkers from clinic visits in one place.

๐Ÿ“

Measurements

Waist, hip, and other measurements reveal changes the scale may miss.

๐Ÿ˜ด

Notes & Mood

Daily notes on energy, appetite, sleep, and overall wellbeing.

How to Track Your Orforglipron Protocol

01

Set a baseline: log your starting weight, measurements, and any available labs before your first dose

02

Record every dose: date, amount, injection site, and any immediate reactions

03

Log weekly weight at the same time and conditions to track your trend

04

Note side effects with severity so your prescriber can adjust your protocol

05

Add lab results from each clinic visit to measure biomarker improvements over time

Orforglipron Key Facts

Category

Oral GLP-1 (Lilly)

Orforglipron

Status

Investigational

ATTAIN

Typical Dose

12-36-72 mg/day

12-36-72 mg/day

Protocol FAQs

A once-daily oral small-molecule GLP-1 receptor agonist from Eli Lilly. No injections, no fasting requirements. Phase 3 trials show up to 12.4% weight loss. FDA approval expected mid-2026.

Open Shotlee, select orforglipron, log your daily tablet, and track weight and side effects. Daily reminders keep you consistent.

Yes โ€” orforglipron tracking is completely free forever. Premium AI features are available optionally.

Open the Shotlee app, navigate to the dose logging screen, select Orforglipron as your medication, and enter the dose amount, injection site, and time. Shotlee stores all entries with timestamps and lets you view your complete dose history, adherence rate, and missed dose alerts. The app is free to download and use.

The most important side effects to track include gastrointestinal symptoms (nausea, vomiting, diarrhea, constipation), injection site reactions, appetite changes, energy levels, and any unusual symptoms. Log these daily in Shotlee so you can share accurate trend data with your healthcare provider at your next visit.

Most patients begin noticing appetite changes within the first one to two weeks. Measurable weight loss typically becomes apparent by weeks four to eight, depending on the dose titration schedule and individual metabolic response. Track your weekly weight in Shotlee to visualize your personal response curve over time.

References

  1. [1]Clinical TrialWharton S et al. Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. N Engl J Med. 2023;389(10):877-888.

Track Your Orforglipron Protocol in Shotlee

Free dose logs, side effect tracking, weight trends, and lab results โ€” all in one app.

๐Ÿš€ Use Shotlee for Free